Literature DB >> 12232957

Influence of commercial information on prescription quantity in primary care.

Francisco Caamaño1, Adolfo Figueiras, Juan Jesus Gestal-Otero.   

Abstract

BACKGROUND: In the last few years we have witnessed many publicly-financed health services reaching a crisis point. Thus, drug expenditure is nowadays one of the main concerns of health managers, and its containment one of the first goals of health authorities in western countries. The objective of this study is to identify the effect of the perceived quality stated in commercial information, its uses, and how physicians perceive the influence it has on prescription amounts.
METHODS: A cross-sectional study of 405 primary care physicians was conducted in Galicia (north-west Spain). The independent variables physician's education and speciality, physician's perception of the quality of available drug information sources, type of practice, and number of patients were collected, through a postal questionnaire. Environmental characteristics of the practice were obtained from secondary sources. Multiple regression models were constructed using as dependent variables two indicators of prescription volume.
RESULTS: The response rate was 75.2%. Prescription amounts was found to be associated with perceived credibility of information provided by medical visitors, regulated physician training, and environmental characteristics of the practice (primary care team practice, urban environment).
CONCLUSIONS: The study results suggest that in order to decrease prescription amounts it is necessary to limit the role of pharmaceutical companies in physician training, improve physician education and training, and emphasize more objective sources of information.

Entities:  

Mesh:

Year:  2002        PMID: 12232957     DOI: 10.1093/eurpub/12.3.187

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  17 in total

Review 1.  Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis.

Authors:  Hneine Brax; Racha Fadlallah; Lina Al-Khaled; Lara A Kahale; Hala Nas; Fadi El-Jardali; Elie A Akl
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

2.  General practitioners and pharmaceutical sales representatives: quality improvement research.

Authors:  Geoffrey Spurling; Peter Mansfield
Journal:  Qual Saf Health Care       Date:  2007-08

3.  Characteristics of primary health care units with focus on drug information from the pharmaceutical industry and adherence to prescribing objectives: a cross-sectional study.

Authors:  Daniel Carlzon; Lena Gustafsson; Anna L Eriksson; Karin Rignér; Anders Sundström; Susanna M Wallerstedt
Journal:  BMC Clin Pharmacol       Date:  2010-02-15

Review 4.  Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review.

Authors:  Geoffrey K Spurling; Peter R Mansfield; Brett D Montgomery; Joel Lexchin; Jenny Doust; Noordin Othman; Agnes I Vitry
Journal:  PLoS Med       Date:  2010-10-19       Impact factor: 11.069

5.  GPs' opinions of public and industrial information regarding drugs: a cross-sectional study.

Authors:  Ingmarie Skoglund; Cecilia Björkelund; Kirsten Mehlig; Ronny Gunnarsson; Margareta Möller
Journal:  BMC Health Serv Res       Date:  2011-08-25       Impact factor: 2.655

6.  Attitudes of primary care physicians to the prescribing of antibiotics and antimicrobial resistance: a qualitative study from Spain.

Authors:  Juan M Vazquez-Lago; Paula Lopez-Vazquez; Ana López-Durán; Margarita Taracido-Trunk; Adolfo Figueiras
Journal:  Fam Pract       Date:  2011-10-19       Impact factor: 2.267

7.  Use of and attitudes towards the prescribing guidelines booklet in primary health care doctors.

Authors:  Magnus A B Axelsson; Malin Spetz; Anders Mellén; Susanna M Wallerstedt
Journal:  BMC Clin Pharmacol       Date:  2008-09-22

8.  A survey of pharmaceutical company representative interactions with doctors in Libya.

Authors:  Mustafa A Alssageer; Stefan R Kowalski
Journal:  Libyan J Med       Date:  2012-09-18       Impact factor: 1.657

9.  A randomized controlled trial comparing two ways of providing evidence-based drug information to GPs.

Authors:  Ingmarie Skoglund; Cecilia Björkelund; Max Petzold; Ronny Gunnarsson; Margareta Möller
Journal:  Scand J Prim Health Care       Date:  2013-03-06       Impact factor: 2.581

10.  What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?

Authors:  Mustafa Ali Alssageer; Stefan Robert Kowalski
Journal:  Pan Afr Med J       Date:  2013-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.